Literature DB >> 26947067

The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.

Che-Pei Kung1, Julia I-Ju Leu2, Subhasree Basu1, Sakina Khaku1, Frederick Anokye-Danso3, Qin Liu4, Donna L George2, Rexford S Ahima3, Maureen E Murphy5.   

Abstract

p53 is well known for its tumor suppressor role, but this protein also has a poorly understood role in the regulation of metabolism. Human studies have implicated a common polymorphism at codon 72 of p53 in diabetic and pre-diabetic phenotypes. To understand this role, we utilized a humanized mouse model of the p53 codon 72 variants and monitored these mice following challenge with a high-fat diet (HFD). Mice with the arginine 72 (R72) variant of p53 developed more-severe obesity and glucose intolerance on a HFD, compared to mice with the proline 72 variant (P72). R72 mice developed insulin resistance, islet hypertrophy, increased infiltration of immune cells, and fatty liver disease. Gene expression analyses and studies with small-molecule inhibitors indicate that the p53 target genes Tnf and Npc1l1 underlie this phenotype. These results shed light on the role of p53 in obesity, metabolism, and inflammation.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ccl2; NAFLD; Npc1l1; Pck1; Tnf; diabetes; inflammation; islet hypertrophy; lipid metabolism; obesity; p53

Mesh:

Substances:

Year:  2016        PMID: 26947067      PMCID: PMC4926645          DOI: 10.1016/j.celrep.2016.02.037

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  59 in total

1.  p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.

Authors:  Kengo Tomita; Toshiaki Teratani; Takahiro Suzuki; Tetsuya Oshikawa; Hirokazu Yokoyama; Katsuyoshi Shimamura; Kiyoshi Nishiyama; Norikazu Mataki; Rie Irie; Tohru Minamino; Yoshikiyo Okada; Chie Kurihara; Hirotoshi Ebinuma; Hidetsugu Saito; Ippei Shimizu; Yohko Yoshida; Ryota Hokari; Kazuo Sugiyama; Kazuo Hatsuse; Junji Yamamoto; Takanori Kanai; Soichiro Miura; Toshifumi Hibi
Journal:  J Hepatol       Date:  2012-05-26       Impact factor: 25.083

2.  Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia.

Authors:  Hong Shi; Si-jie Tan; Hua Zhong; Wenwei Hu; Arnold Levine; Chun-jie Xiao; Yi Peng; Xue-bin Qi; Wei-hua Shou; Run-lin Z Ma; Yi Li; Bing Su; Xin Lu
Journal:  Am J Hum Genet       Date:  2009-04-02       Impact factor: 11.025

Review 3.  Regulation of lipid metabolism by p53 - fighting two villains with one sword.

Authors:  Ido Goldstein; Varda Rotter
Journal:  Trends Endocrinol Metab       Date:  2012-07-20       Impact factor: 12.015

4.  Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.

Authors:  J L Luo; Q Yang; W M Tong; M Hergenhahn; Z Q Wang; M Hollstein
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

5.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 6.  Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.

Authors:  Francesca De Iuliis; Gerardo Salerno; Ludovica Taglieri; Susanna Scarpa
Journal:  Cancer Chemother Pharmacol       Date:  2015-07-22       Impact factor: 3.333

7.  Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.

Authors:  John Willy Haukeland; Jan Kristian Damås; Zbigniew Konopski; Else Marit Løberg; Terese Haaland; Ingeborg Goverud; Peter A Torjesen; Kåre Birkeland; Kristian Bjøro; Pål Aukrust
Journal:  J Hepatol       Date:  2006-03-20       Impact factor: 25.083

Review 8.  Interactions between the tumor suppressor p53 and immune responses.

Authors:  Daniel Menendez; Maria Shatz; Michael A Resnick
Journal:  Curr Opin Oncol       Date:  2013-01       Impact factor: 3.645

Review 9.  On the evolutionary origins of obesity: a new hypothesis.

Authors:  Dyan Sellayah; Felino R Cagampang; Roger D Cox
Journal:  Endocrinology       Date:  2014-02-26       Impact factor: 4.736

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  54 in total

Review 1.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

Review 2.  Epigenomic and transcriptional control of insulin resistance.

Authors:  E D Rosen
Journal:  J Intern Med       Date:  2016-10-14       Impact factor: 8.989

Review 3.  Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility.

Authors:  Rebecca A Jackson; Mai Linh Nguyen; Angela N Barrett; Yuan Yee Tan; Mahesh A Choolani; Ee Sin Chen
Journal:  Cell Mol Life Sci       Date:  2016-05-31       Impact factor: 9.261

4.  A link between TP53 polymorphisms and metabolism.

Authors:  Che-Pei Kung; Subhasree Basu; Maureen E Murphy
Journal:  Mol Cell Oncol       Date:  2016-04-15

5.  The African-specific S47 polymorphism of p53 alters chemosensitivity.

Authors:  Subhasree Basu; Thibaut Barnoud; Che-Pei Kung; Matthew Reiss; Maureen E Murphy
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

6.  The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.

Authors:  Che-Pei Kung; Qin Liu; Maureen E Murphy
Journal:  Cancer Biol Ther       Date:  2017-05-05       Impact factor: 4.742

7.  The Codon 72 TP53 Polymorphism Contributes to TSC Tumorigenesis through the Notch-Nodal Axis.

Authors:  Jun-Hung Cho; Bhaumik Patel; Santosh Bonala; Hossein Mansouri; Sasikanth Manne; Surya Kumari Vadrevu; Shanawaz Ghouse; Che-Pei Kung; Maureen E Murphy; Aristotelis Astrinidis; Elizabeth P Henske; David J Kwiatkowski; Maciej M Markiewski; Magdalena Karbowniczek
Journal:  Mol Cancer Res       Date:  2019-05-14       Impact factor: 5.852

8.  TP53 single nucleotide polymorphism (rs1042522) in Iranian patients with coronary artery disease.

Authors:  Versa Omrani-Nava; Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei; Vahid Mokhberi; Rozita Jalalian; Ghasem Janbabaei; Omolbanin Amjadi; Ghasem Rahmatpour; Amir Mozaffari
Journal:  Biomed Rep       Date:  2018-07-02

Review 9.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

10.  The transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53.

Authors:  Anna Budina-Kolomets; Thibaut Barnoud; Maureen E Murphy
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.